Cancer of the anus or anal canal is a rare colorectal malignancy. It is typically a loco-regional disease with current standard of care been mainly radio-chemotherapy. This allows organ preservation and better functional control. Surgical procedures can be considered however it tends to be offered in second line therapy for either the management of recurrence as well as bowel diversion. The aim of this study is to provide a concise review of our institutional experience in the management of anal cancer. A retrospective analysis 46 patients treated between 2004-2014 was performed. The incidence of recurrence as well as overall survival were analysed using Kaplan-Meier method. The median age at diagnosis was 68 year of age. The median follow up of the cohort was 46 months. The overall 5 year survival was 52%. This study is a contemporaryAustralian series examining the survival trends of anal cancer. Perhaps more research is needed to determine if targeted therapy for loco-regional control will benefit those patients with locally advanced disease.